AF
QNCX icon

Allworth Financial’s Quince Therapeutics QNCX Stock Holding History

Allworth Financial’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8
Closed -$5.03K – 5294
2025
Q4 		$5.03K Buy
+8
New +$4.03K ﹤0.01% 3709
2023
Q4 		– Sell
-1
Closed -$300 – 3586
2023
Q3 		$300 Hold
1
– – ﹤0.01% 3169
2023
Q2 		$402 Hold
1
– – ﹤0.01% 2936
2023
Q1 		$417 Buy
+1
New +$196 ﹤0.01% 2877

Other funds holding QNCX

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Allworth Financial's QNCX Position: Q1 2026 in Review

Allworth Financial sold out of Quince Therapeutics (QNCX) in Q1 2026, closing a stake of 8 shares — an estimated $5.03K sold.

Allworth Financial first reported a position in QNCX in Q1 2023 and held it in 4 quarters. The position peaked at $5.03K in Q4 2025. 43 funds tracked by Wall St. Rank hold QNCX as of Q1 2026.

  • Allworth Financial reported no remaining Quince Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Allworth Financial sold 8 Quince Therapeutics shares in Q1 2026, an estimated $5.03K.
  • Allworth Financial first reported a position in Quince Therapeutics in Q1 2023 and held it in 4 quarters.
  • Allworth Financial's Quince Therapeutics position peaked at $5.03K in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Quince Therapeutics as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.